92
Views
6
CrossRef citations to date
0
Altmetric
Research Report

Does adjusting for health-related quality of life matter in economic evaluations of cancer-related interventions?

&
Pages 113-119 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Matthias Schwenkglenks & Klazien Matter-Walstra. (2016) Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 207-219.
Read now

Articles from other publishers (5)

Teja ThoratPeter J. NeumannJames D. Chambers. (2018) Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia. Journal of Managed Care & Specialty Pharmacy 24:7, pages 632-642.
Crossref
Scott Grosse. (2015) When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives. Healthcare 3:4, pages 860-878.
Crossref
David E. Cohn, Jason C. Barnett, Lari Wenzel, Bradley J. Monk, Robert A. Burger, J. Michael StraughnJr.Jr., Evan R. Myers & Laura J. Havrilesky. (2015) A cost–utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer. Gynecologic Oncology 136:2, pages 293-299.
Crossref
Nalin Payakachat, J. Mick Tilford, Karen A. Kuhlthau, N. Job van Exel, Erica Kovacs, Jayne Bellando, Jeffrey M. Pyne & Werner B.F. Brouwer. (2014) Predicting Health Utilities for Children With Autism Spectrum Disorders. Autism Research 7:6, pages 649-663.
Crossref
Joanna Jakubiak-Lasocka & Michał Jakubczyk. (2014) Cost-effectiveness versus Cost-Utility Analyses: What Are the Motives Behind Using Each and How Do Their Results Differ?—A Polish Example. Value in Health Regional Issues 4, pages 66-74.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.